European Lithium Puts a Dollar Figure on Its Nasdaq Bet — But the Final Payout Still Swings on a Floating Formula

European Lithium's 31% CRML stake valued at $303.3M; variable exchange ratio and DoD investment boost deal prospects.

Investors in European Lithium finally have a number to anchor their merger math. On 25 August, the company disclosed that its 31% stake in Nasdaq-listed Critical Metals Corp was worth roughly US$303.3 million, based on a closing price of US$6.66 for CRML shares — equivalent to about A$429.1 million. For a stock that has spent months trading on the promise of a transatlantic tie-up, that valuation provides the first concrete sense of what the deal could deliver.

The timing was telling. Just a day later, CRML shares surged nearly 18% in a single session to US$7.87. Analysts pointed to two catalysts: a reworked merger agreement designed to cushion downside, and the finalisation of a US$750 million investment from the US Department of Defense into domestic rare earth supply chains.

That rally matters more than it might appear. Because the exchange ratio agreed in August is now variable — capped and floored between 0.025 and 0.045 new CRML shares per European Lithium share, calculated using a 20-day volume-weighted average price — every tick in Critical Metals' stock feeds directly into the implied value of the deal for European Lithium holders.

A Floating Ratio Built to Absorb Shock

The shift to a variable exchange rate was formalised in the second amendment to the Scheme Implementation Deed. The original fixed ratio was scrapped in favour of the banded structure, a mechanism intended to shield shareholders from exactly the kind of volatility that has defined both stocks in recent weeks. It is a design that acknowledges a simple reality: the value European Lithium investors ultimately receive will be determined less by their own company's share price and more by where CRML trades when the VWAP calculation window opens.

That dependency cuts both ways. A strong CRML run lifts the implied consideration; a slide erodes it. The 25 August valuation, calculated before the defence department news broke, already justified a substantial portion of European Lithium's current market capitalisation of roughly €399 million — and that was before the subsequent jump in CRML's share price.

Wolfsberg's Status Holds Steady Through the Noise

Amid the merger mechanics, the operational anchor remains intact. Critical Metals has confirmed that the Wolfsberg lithium project in Austria still holds its status as Europe's first fully permitted lithium mine. The project is progressing toward production, supported by existing offtake and downstream partnerships. For European Lithium shareholders, that designation is more than a regulatory badge — Wolfsberg forms the European core of the combined entity that will emerge once the merger completes.

The broader lithium backdrop has also brightened. Fitch-owned BMI lifted its forecast for global production growth in 2026 to 13.2% year-on-year, citing a first-half recovery in lithium prices that has made it viable for higher-cost Australian operations to restart. A firmer pricing environment could, in turn, support the valuation assigned to Wolfsberg within the merger framework.

The Timeline Holds, the Paperwork Mounts

The transaction calendar has not shifted. The scheme booklet, including the independent expert's report, remains scheduled for dispatch to shareholders in early September, with implementation of the merger targeted for October 2026, subject to shareholder and court approval.

Meanwhile, the share register is quietly growing. European Lithium has reported the admission of 193,019 new ordinary shares to trading on the Australian exchange, issued following the exercise or conversion of existing options and convertible instruments.

A Stock That Trades on Someone Else's Tape

The market's reaction to all this has been characteristically uneven. European Lithium shares closed at €0.2330 on Thursday, up 1.8% on the day, though a separate session saw the stock at €0.2340, marginally below the prior close of €0.2350. Over 30 days, the share price has climbed 51% — or 47% depending on the measurement window — and it remains up 157% since the start of the year. The stock still sits 24% below its 52-week high of €0.3055, reached in early June, but holds comfortably above its 50-day moving average of €0.2016.

Volatility, annualised at 96%, tells its own story: the market is still pricing in the intricacies of the variable exchange ratio and the merger timetable. The 25 August valuation gives investors a reference point, but the decisive variable remains the trajectory of CRML shares between now and October. With the scheme booklet due to land in early September, shareholders should soon have the independent expert's view on whether the deal's logic is already reflected in the current price — or whether the floating formula still leaves room on the table.